Korea Institute of Toxicology, KRICT, Daejeon, Korea.
Toxicol Res. 2013 Mar;29(1):53-60. doi: 10.5487/TR.2013.29.1.053.
Studies on milk transfer of drugs in non-human primates (NHPs) are among the crucial components in the assessment of peri- and postnatal toxicity because of the similarity between NHPs and humans. To evaluate the milk transfer of valproic acid (VPA) in NHPs, the toxicokinetics of VPA, an antiepileptic drug, were studied in pregnant cynomolgus monkeys. VPA was administered once daily to pregnant cynomolgus monkeys at doses of 0, 30, 90, and 270 mg/kg by oral gavage from Day 100 of gestation (GD 100) to Day 31 of lactation (LD 31). Concentrations of VPA and its metabolite, 4-ene-VPA, in the maternal plasma on GD 100, GD 140, and LD 30, and concentrations of VPA and 4-ene-VPA in the offspring plasma and milk on LDs 30 and 31, respectively, were quantified using liquid chromatography tandem mass spectrometry (LC/MS/MS). After administration of a single oral dose of VPA to pregnant monkeys on GD 100, the concentrations of VPA and 4-ene-VPA were generally quantifiable in the plasma of all treatment groups up to 24 hr after administration, which showed that VPA was absorbed and that the monkeys were systemically exposed to VPA and 4-ene-VPA. After administration of multiple doses of VPA to the monkeys, VPA was detected in the pup's plasma and in milk taken on LD 30 and LD 31, respectively, which showed that VPA was transferred via milk, and the pup was exposed to VPA. Further, the concentration of VPA in the milk increased with an increase in the dose. Extremely low concentrations of 4-ene VPA were detected in the milk and in the pup plasma. In conclusion, pregnant monkeys were exposed to VPA and 4-ene-VPA after oral administration of VPA at doses of 30, 90, and 270 mg/kg/day from GD 100 to LD 31. VPA was transferred via milk, and the VPA exposure to the pup increased with an increase in the dose of VPA. The metabolite, 4-ene VPA, was present in extremely low concentrations (< 0.5 μg/ml) in the milk and in the pup plasma. In this study, we established methods to confirm milk transfer in NHPs, such as mating and diagnosis of pregnancy by examining gestational sac with ultrasonography, collection of milk and pup plasma and determination of toxicokinetics, using cynomolgus monkeys.
在非人类灵长类动物(NHPs)中进行药物的乳汁转移研究是评估围产期和产后毒性的关键组成部分,因为 NHPs 与人类非常相似。为了评估丙戊酸(VPA)在 NHP 中的乳汁转移情况,研究了抗癫痫药物 VPA 在妊娠恒河猴中的毒代动力学。从妊娠第 100 天(GD 100)到哺乳期第 31 天(LD 31),通过口服灌胃每天一次向妊娠恒河猴给予 0、30、90 和 270mg/kg 的 VPA。在 GD 100、GD 140 和 LD 30 时,使用液相色谱串联质谱法(LC/MS/MS)定量测定母血浆中 VPA 及其代谢物 4-ene-VPA 的浓度,以及在 LD 30 和 LD 31 时,分别测定子代血浆和乳汁中 VPA 和 4-ene-VPA 的浓度。在 GD 100 时给怀孕猴子单次口服 VPA 给药后,所有治疗组的母血浆中 VPA 和 4-ene-VPA 的浓度在给药后 24 小时内通常均可定量检测,这表明 VPA 被吸收,猴子系统暴露于 VPA 和 4-ene-VPA。给猴子多次给予 VPA 后,分别在 LD 30 和 LD 31 时在幼崽的血浆和乳汁中检测到 VPA,这表明 VPA 通过乳汁转移,幼崽暴露于 VPA。此外,随着剂量的增加,乳汁中 VPA 的浓度增加。在乳汁和幼崽血浆中检测到极低浓度的 4-ene VPA。总之,从 GD 100 到 LD 31,给怀孕猴子口服 VPA 30、90 和 270mg/kg/天时,猴子暴露于 VPA 和 4-ene-VPA。VPA 通过乳汁转移,VPA 对幼崽的暴露量随 VPA 剂量的增加而增加。代谢物 4-ene VPA 在乳汁和幼崽血浆中的浓度非常低(<0.5μg/ml)。在这项研究中,我们建立了使用恒河猴确认乳汁转移的方法,例如交配和通过超声检查检查妊娠囊来诊断妊娠,收集乳汁和幼崽血浆并测定毒代动力学。